Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice
Authors:
- Harold D. SnoddyHSHarold D. Snoddy
- 1 October 1993
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 32 (10) , 995-999
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The effect of nefopam and its enantiomers on the uptake of 5-hydroxytryptamine, noradrenaline and dopamine in crude rat brain synaptosomal preparationsJournal of Pharmacy and Pharmacology, 1990
- The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitorJournal of Medicinal Chemistry, 1988
- Antinociceptive effects of (±)-, (+)- and (-)-nefopam in miceJournal of Pharmacy and Pharmacology, 1987
- Involvement of central serotogenic pathways in nefopam-induced antiniciceptionEuropean Journal of Pharmacology, 1987
- Evidence of the involvement of dopamine in the analgesic effect of nefopamEuropean Journal of Pharmacology, 1986
- Spinal and supraspinal sites for morphine and nefopam analgesia in the mouseEuropean Journal of Pharmacology, 1981
- NefopamDrugs, 1980
- Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin—comparison of fluoxetine and chlorimipramineBiochemical Pharmacology, 1978
- Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolismNeuropharmacology, 1975
- Comparison of the specificity of 3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenypropylamine and chlorimipramine as amine uptake inhibitors in miceEuropean Journal of Pharmacology, 1974